Add BrightSurf on Google Email

Cincinnati Children's Hospital Medical Center


New biomarker allows early detection of adverse prognosis after acute kidney injury

A new biomarker called NGAL in urine or blood detects early subclinical AKI and its adverse outcomes in critically ill patients, allowing for earlier conventional medical interventions. The study's findings justify redefining what defines AKI and recommend using NGAL-based testing to improve prognosis.

SourceCincinnati Children's Hospital Medical Center·JournalJournal of the American College of Cardiology·DateApr 18, 2011

Researchers identify biomarkers of poor outcomes in preemies

A study by Dr. Ardythe Morrow at Cincinnati Children's Hospital Medical Center found that preterm infants with a specific genetic variant (FUT2) are more likely to experience bad outcomes, including death and sepsis. The researchers identified a link between low levels of 'H antigen' in saliva and increased risk of disease progression.

SourceCincinnati Children's Hospital Medical Center·JournalThe Journal of Pediatrics·DateJan 27, 2011

Scientists successfully reprogram blood cells

Researchers have successfully transplanted genetically modified hematopoietic stem cells into mice, allowing their developing red blood cells to produce a critical lysosomal enzyme and preventing or reducing organ and central nervous system damage from Hurler's syndrome. This approach has the potential to improve treatment options for ...

SourceCincinnati Children's Hospital Medical Center·JournalProceedings of the National Academy of Sciences·DateNov 9, 2009

Scientists identify gene for short-circuiting excess mucus in lung disease, common colds

Researchers have identified a genetic switch that causes excessive mucus in the lungs, shedding light on a medical mystery. The study found that a transcription factor called SPDEF regulates a chain of genes involved in mucus production, and blocking its influence may be a potential pathway for new treatments.

SourceCincinnati Children's Hospital Medical Center·JournalJournal of Clinical Investigation·DateSep 14, 2009

Inherited genetic cause, possible treatment found for complex lung disorder

A Cincinnati Children's study identifies a familial genetic cause for Pulmonary Alveolar Proteinosis (PAP), a lung disease causing labored breathing and respiratory failure. The research team proposes an inhaled GM-CSF aerosol as a potential treatment to correct surfactant levels, offering new hope for patients suffering from the condi...

SourceCincinnati Children's Hospital Medical Center·JournalJournal of Experimental Medicine·DateNov 24, 2008